文章摘要

结节性甲状腺肿术后促甲状腺激素抑制治疗研究进展

作者: 1殷剑光, 1谈坚
1 上海交通大学医学院附属瑞金医院古北分院 / 民航上海医院 普通外科，上海 200336
通讯: 谈坚 Email: drqwh2003@126.com
DOI: 10.3978/.10.3978/j.issn.1005-6947.2017.11.015

摘要

结节性甲状腺肿是普通外科领域常见疾病之一，外科手术后有较高的复发率，为后续治疗提出了挑战。 而通过术后规范的甲状腺素治疗，可以使患者的术后促甲状腺激素(TSH)抑制，并控制在一个合理 的水平，能明显减少结节性甲状腺肿术后的复发。笔者就结节性甲状腺肿术后 TSH 抑制治疗的进展进 行综述。
关键词： 甲状腺肿，结节性 促甲状腺素 激素替代疗法 综述文献

Research progress of thyroid-stimulating hormone suppressive therapy for nodular goiter after surgery

Authors: 1Yin Jianguang, 1Tan Jian
1 Department of General Surgery, Gubei Branch of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine/Civil Aviation Shanghai Hospital, Shanghai 200336, China

CorrespondingAuthor:Tan Jian Email: drqwh2003@126.com

Abstract

Nodular goiter is a common disease in the eld of general surgery, and has a high postoperative recurrence rate, which poses a challenge for following treatment. Nevertheless, standardized postoperative thyroxine treatment can effectively reduce postoperative recurrence of the nodular goiter by inhibiting the thyroid-stimulating hormone (TSH) of the patients and controlling it at a proper level a er operation. Here, the authors address the progress of postoperative TSH suppressive therapy for nodular goiter patients.
Keywords： Goiter Nodular yrotropin Hormone Replacement erapy Review